Cardiovascular Renal Metabolic

ERA 25: Albuminuria, eGFR Dip and Disease Severity & Empagliflozin

William Herrington

Watch time: 3m 10s
ERA 25: Treating Obesity in 2025 and Beyond

Ruben Nogueiras

Watch time: 4m 16s
ERA 25: Switching from sMRAs to Finerenone

Beatriz Fernandez Fernandez

Watch time: 10m 48s
ERA 25: eGFR Dips and Disease Severity on Empagliflozin

Watch time: 2m 52s
Real-World Data for CV and Renal Outcomes in DKD

David Wheeler

Watch time: 2m 39s

Paola Fioretto, Rajiv Agarwal

Watch time: 28m 13s (3 videos)

William Herrington

Watch time: 3m 10s (9 videos)
Liver Stiffness to Assess Central Venous Pressure in HF

Nicolas Girerd

Watch time: 2m 40s
Kidney Function Trajectories Before and After HF Hospitalisation

Nicolas Girerd

Watch time: 4m 39s
ESC HF 25: The FIVE-STAR Trial

Watch time: 2m 40s
ESCHFA25: FINEARTS-HF: Finerenone Risk-Benefit Across Kidney Function

Safia Chatur

Watch time: 5m 49s
ESC HF 25: The PRAISE-HFrEF Study

Varun Sundaram

Watch time: 4m 10s

David Wheeler, Carol Pollock,

Muthiah Vaduganathan

Sydney Tang , ,

Stefan Anker, Shelley Zieroth, Andrew JS Coats, et al

Watch time: 5h 14m 55s (31 videos)

Lee Kaplan, Fatima Cody Stanford, Filip Knop, et al

Andrew JS Coats, Stefan Anker

Neha Pagidipati, Linda Mellbin, , et al

Watch time: 2h (19 videos)

James Burton, Shelley Zieroth, Clara Bonanad Lozano , et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, John Spertus, , et al

Debbie L Cohen, Raymond R Townsend

Raymond B Fohtung, Michael W Rich

Read time: 13m 29s

Paul Kalra

Watch time: 12m 41s (2 videos)

Media

AHA 23: Preventive Cardiology in 2023

Michael Honigberg

Watch time: 7m 3s
AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
AHA 23 Late-Breaker Discussion: The SELECT Trial

A Michael Lincoff , Harriette Van Spall

Watch time: 21m 35s
CardioNerds @AHA23: Presidential Advisory on CKM Health

Ramy Doss, Chiadi Ndumele

Watch time: 14m 32s
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial

Harriette Van Spall, Mikhail Kosiborod

Watch time: 13m 24s
ESC 23: Day 1 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Mirvat Alasnag, Khaled Al-Shaibi

Watch time: 13m 28s
ECO 23: Impact of Obesity on Heart Failure Outcomes

Laura Meems

Watch time: 7m 7s

James Burton, Shelley Zieroth, Clara Bonanad Lozano , et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, John Spertus, , et al

Obesity Management Strategies in 2023

Harold Bays

Watch time: 17m 7s
ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s
EP 87: Gut Microbiome and Heart Health: The 3 Compounds You Need to Know About with Dr Vuyisich

Ankur Kalra, Momchilo Vuyisich,

Listen time: 45m 50s

Media

ESC HF 25: The PRAISE-HFrEF Study

Varun Sundaram

Watch time: 4m 10s

William Herrington

Watch time: 3m 10s (9 videos)
ERA 25: Albuminuria, eGFR Dip and Disease Severity & Empagliflozin

William Herrington

Watch time: 3m 10s
Kidney Function Trajectories Before and After HF Hospitalisation

Nicolas Girerd

Watch time: 4m 39s
Liver Stiffness to Assess Central Venous Pressure in HF

Nicolas Girerd

Watch time: 2m 40s

Broadcast

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
Advancements in Obesity Management (AOM) 2025

Harold Bays, Naveed Sattar, Liesbeth van Rossum, et al

View from the Thoraxcenter: What's Hot at ACC.24?

Nicolas M Van Mieghem, Joost Daemen

Watch time: 28m 9s
View from the Thoraxcenter: ACC.24 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen

Watch time: 43m 48s

Paola Fioretto, Rajiv Agarwal

Watch time: 28m 13s (3 videos)
View from the Thoraxcenter: What's Hot at AHA 24?

Joost Daemen, Nicolas M Van Mieghem

Watch time: 13m 43s
ERA 25: Switching from sMRAs to Finerenone

Beatriz Fernandez Fernandez

Watch time: 10m 48s
ERA 25: Treating Obesity in 2025 and Beyond

Ruben Nogueiras

Watch time: 4m 16s

Articles

Homocysteine-lowering Treatment in Reduction of Stroke and Coronary Vascular Risk - Do Not Give Up

Wolfgang Herrmann

,

Rima Obeid

,

Citation:

US Cardiology 2009;6(1):36–40

DOI:

https://doi.org/10.15420/usc.2009.6.1.36
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 470
  • Downloads: Downloads 0

Prevention of Cardiovascular Risk in Diabetic Patients - An Update

Peter M Nilsson

,

Citation:

US Cardiology 2007;4(2):19–21

DOI:

https://doi.org/10.15420/usc.2007.4.2.19
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 532
  • Downloads: Downloads 1

Effect of Pioglitazone Compared with Glimepiride on Carotid Intima-media Thickness in Type 2 Diabetes

Theodore Mazzone

,

Citation:

US Cardiology 2007;4(1):25–30

DOI:

https://doi.org/10.15420/usc.2007.4.1.25
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 426
  • Downloads: Downloads 1

Detection of Silent Coronary Artery Disease in Asymptomatic Patients with Type 2 Diabetes Mellitus

Frans J Th Wackers

,

Janice A Davey

,

Citation:

US Cardiology 2005;2(1):1-4

Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1146
  • Downloads: Downloads 4